Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Medicus Pharma Ltd. Common Stock
Market Cap
$9.99M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$10.18M
Net Profit Margin
0.00%
TTM Avg
-496.48%
3Y Avg
-440.58%
5Y Avg
-356.69%
Market Cap
$9.98M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-312.43%
5Y Avg
-391.43%
Market Cap
$9.97M
Net Profit Margin
-90116.36%
TTM Avg
-139631.82%
3Y Avg
-71156.88%
5Y Avg
-48680.54%
Market Cap
$9.73M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.79M
Net Profit Margin
-106283.32%
TTM Avg
-41799.65%
3Y Avg
-23818.56%
5Y Avg
-17447.75%
Market Cap
$11.13M
Net Profit Margin
N/A
TTM Avg
-2424.09%
3Y Avg
-1624.47%
5Y Avg
-1082.98%
Market Cap
$9.66M
Net Profit Margin
-71.51%
TTM Avg
-193.27%
3Y Avg
-1708.98%
5Y Avg
-2188.03%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $9.99M | 0.00% | 0.00% | 0.00% | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | 0.00% | -496.48% | -440.58% | -356.69% |
| Valion Bio, Inc. (VBIO)vs › | $9.98M | 0.00% | 0.00% | -312.43% | -391.43% |
| Senti Biosciences, Inc. (SNTI)vs › | $9.97M | -90116.36% | -139631.82% | -71156.88% | -48680.54% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.73M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ainos, Inc. (AIMD)vs › | $9.79M | -106283.32% | -41799.65% | -23818.56% | -17447.75% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.13M | N/A | -2424.09% | -1624.47% | -1082.98% |
| Polyrizon Ltd. (PLRZ)vs › | $10.52M | N/A | 0.00% | 0.00% | 0.00% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | -71.51% | -193.27% | -1708.98% | -2188.03% |
| MetaVia Inc. (MTVA)vs › | $9.62M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
